Fuzhi Song

Chief Executive Officer at GENEX PHARMACEUTICAL, INC.

70 year

Health Technology

Profile

Fuzhi Song is currently the Chairman, President & Chief Executive Officer at Genex Pharmaceutical, Inc. since 2004 and also the Chairman at Tianjin Zhongjin Biology Development Co. Ltd.
since 2003.
Previously, he was the Chief Executive Officer at Tianjin Zhongjin Pharmageutical Co. Ltd.
from 1998 to 1999 and Chairman at Tianjin Jinshi Group.

Fuzhi Song active positions

Companies	Position	Start
GENEX PHARMACEUTICAL, INC.	Chief Executive Officer	-
Tianjin Zhongjin Biology Development Co. Ltd. Tianjin Zhongjin Biology Development Co. Ltd. Medical SpecialtiesHealth Technology Part of Genex Pharmaceutical, Inc., Tianjin Zhongjin Biology Development Co. Ltd. manufactures and distributes medical devices for healing broken bone injuries. The private company is based in Tianjin, China. Tianjin Zhongjin Biology Development Co. was acquired by Genex Pharmaceutical, Inc. on June 17, 2004 for $7.98 million.	Chairman	2010-02-23

All active positions of Fuzhi Song

Former positions of Fuzhi Song

Companies	Position	End
Tianjin Zhongjin Pharmageutical Co. Ltd.	President	1999-10-31
Tianjin Jinshi Group	Chairman	1998-12-31

See the detail of Fuzhi Song's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Fuzhi Song's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
GENEX PHARMACEUTICAL, INC.	Health Technology

Private companies	3
Tianjin Zhongjin Biology Development Co. Ltd. Tianjin Zhongjin Biology Development Co. Ltd. Medical SpecialtiesHealth Technology Part of Genex Pharmaceutical, Inc., Tianjin Zhongjin Biology Development Co. Ltd. manufactures and distributes medical devices for healing broken bone injuries. The private company is based in Tianjin, China. Tianjin Zhongjin Biology Development Co. was acquired by Genex Pharmaceutical, Inc. on June 17, 2004 for $7.98 million.	Health Technology
Tianjin Zhongjin Pharmageutical Co. Ltd.
Tianjin Jinshi Group

See company connections